Laurus Labs Limited sell "Active Pharmaceutical Ingredients"

Building on strong chemical development and manufacturing capabilities, Laurus Labs has built an in-house range of APIs and related intermediates, targeting chemistries where it can add real value—pairing innovation with efficiency through cost-effective processes and matching capacity investment for supply reliability. Laurus ranks among the world's leading suppliers of anti-retroviral APIs and intermediates, with low-cost technologies intended to widen medicine access globally. The company partners closely with innovators, global health organizations, and providers to meet cost-reduction goals without compromising quality, and its facilities for handling highly potent materials at development and commercial scale support oncology as a core focus area.